Hoth Therapeutics (HOTH)
(Delayed Data from NSDQ)
$1.32 USD
-0.06 (-4.35%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $1.32 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth F Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Hoth Therapeutics, Inc. has a market cap of $18.23M, which represents its share price of $1.38 multiplied by its outstanding shares number of 13.21M. As a small-cap company, HOTH's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
HOTH 1.32 -0.06(-4.35%)
Will HOTH be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for HOTH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HOTH
Biotech Stock Roundup: NMRA Plunges on Study Failure, HOTH, VIR Soar on Study Data & More
HOTH Stock Soars as Skin Toxicity Study in Cancer Patients Meets Goal
HOTH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Hoth Stock Up as Lead Drug Heals Skin Toxicities in Cancer Patient
Other News for HOTH
Hoth Therapeutics (HOTH) Receives Buy Rating from D. Boral Capital | HOTH Stock News
Hoth Therapeutics (HOTH) Expands Phase II Trial for Skin Toxicity Treatment
Hoth Therapeutics extending Phase II trial of HT-001 in cancer patients to EU
Hoth Therapeutics Announces Engagement with ICON and Expansion of Phase II Clinical Trial for ...
HOTH Stock: D. Boral Capital Maintains Buy Rating and $5 Price Target | HOTH Stock News